Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
暂无分享,去创建一个
Kutty Selva Nandakumar | C. Ge | R. Toes | T. Winkler | R. Holmdahl | Gordon F Heidkamp | G. Schett | Y. Rombouts | D. Dudziak | M. Herrmann | H. Scherer | W. Schuh | M. Wuhrer | C. Becker | S. Blüml | A. Lux | F. Nimmerjahn | C. Koeleman | I. Magorivska | A. Kleyer | N. Ipseiz | Sybille Böhm | Jochen A. Ackermann | A. Hueber | T. Rothe | G. Krönke | S. Uderhardt | U. Harre | S. Culemann | Patrick Daum | E. Lönnblom | R. Pfeifle | M. Seefried | Benjamin Haugg
[1] M. Okano,et al. Cohort Study , 2020, Definitions.
[2] Sandra Carberry,et al. The Past, the Present, and the Future , 2016, UMAP.
[3] E. Lubberts,et al. The IL-23–IL-17 axis in inflammatory arthritis , 2015, Nature Reviews Rheumatology.
[4] R. Toes,et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss , 2015, Nature Communications.
[5] T. Huizinga,et al. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis , 2015, Annals of the rheumatic diseases.
[6] Ida E. Andersson,et al. Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice , 2014, Arthritis Research & Therapy.
[7] D. van Schaardenburg,et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis , 2013, Annals of the rheumatic diseases.
[8] Anne Herrmann,et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. , 2013, The Journal of clinical investigation.
[9] M. Uhlén,et al. Autoantibody Profiling in Multiple Sclerosis Using Arrays of Human Protein Fragments , 2013, Molecular & Cellular Proteomics.
[10] K. Kikly,et al. IL-23 Dependent and Independent Stages of Experimental Arthritis: No Clinical Effect of Therapeutic IL-23p19 Inhibition in Collagen-induced Arthritis , 2013, PloS one.
[11] B. Stockinger,et al. TH17 cell plasticity in Peyer’s patches is responsible for induction of T cell-dependent IgA responses , 2013, Nature Immunology.
[12] Patrick Durez,et al. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study , 2012, Annals of the rheumatic diseases.
[13] C. Loddenkemper,et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. , 2012, The Journal of allergy and clinical immunology.
[14] T. Yamane,et al. Anticitrullinated Protein Antibody, But Not Its Titer, Is a Predictor of Radiographic Progression and Disease Activity in Rheumatoid Arthritis , 2012, The Journal of Rheumatology.
[15] Magnus Palmblad,et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. , 2012, Journal of proteomics.
[16] B. Pöllinger. IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis , 2012, Journal of Molecular Medicine.
[17] G. Pruijn,et al. Anti-CCP antibodies: the past, the present and the future , 2011, Nature Reviews Rheumatology.
[18] A. Skapenko,et al. Role of Th17 cells in human autoimmune arthritis. , 2010, Arthritis and rheumatism.
[19] Thomas Korn,et al. Proinflammatory T helper type 17 cells are effective B-cell helpers , 2010, Proceedings of the National Academy of Sciences.
[20] Christophe Benoist,et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.
[21] J. Ravetch,et al. Antibody‐mediated modulation of immune responses , 2010, Immunological reviews.
[22] T. Huizinga,et al. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. , 2010, Arthritis and rheumatism.
[23] B. Dijkmans,et al. Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study , 2010, Arthritis research & therapy.
[24] Guzman M Renato,et al. B Cell Depletion in Early Rheumatoid Arthritis: A New Concept in Therapeutics , 2009, Annals of the New York Academy of Sciences.
[25] Robert M. Anthony,et al. Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc , 2008, Science.
[26] Robert W. Williams,et al. Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.
[27] Y. Iwamoto,et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis , 2007, Annals of the rheumatic diseases.
[28] A. Koch. The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.
[29] M. Neurath,et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. , 2006, Journal of immunology.
[30] Kutty Selva Nandakumar,et al. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. , 2005, Journal of immunological methods.
[31] G. Hallmans,et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis , 2004, Arthritis research & therapy.
[32] F. Gruber,et al. Oxidized Phospholipids Induce Expression of Human Heme Oxygenase-1 Involving Activation of cAMP-responsive Element-binding Protein* , 2003, Journal of Biological Chemistry.
[33] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[34] Göran Hallmans,et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.
[35] E. Grant,et al. Essential Role for the C5a Receptor in Regulating the Effector Phase of Synovial Infiltration and Joint Destruction in Experimental Arthritis , 2002, The Journal of experimental medicine.
[36] Ralph Weissleder,et al. Arthritis critically dependent on innate immune system players. , 2002, Immunity.
[37] B. Heyman,et al. Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ Receptors , 2000, The Journal of experimental medicine.
[38] C. Benoist,et al. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.
[39] G. Schuler,et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.
[40] R. Holmdahl,et al. B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA) , 1998, Clinical and experimental immunology.
[41] B. Stockinger,et al. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen , 1994, The Journal of experimental medicine.
[42] L. Klareskog,et al. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. , 1986, Arthritis and rheumatism.
[43] G. Panayi,et al. Autoantigens and immune pathways in rheumatoid arthritis. , 2002, Critical reviews in immunology.